EBS Emergent BioSolutions Inc.
$6.67▲ +5.21%
Healthcare
Other
Pre-market
$6.50▼ -2.55%
Oct 28, 5:22 AM ET
Volume 1.50M
Avg Volume (10D) 1.02M
Key Metrics & Fundamentals
Market Cap
$341.99M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.36 - 14.06
% vs 50 MA
5.26%
% vs 200 MA
-17.59%
RSI-14
52.5
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.09
Free Cash Flow
$54.00M
Gross Rev
$226.80M
Gross Profit
$129.70M
EBITDA
$90.20M
COGS
$97.10M
Operating Exp
$63.50M
Operating Income
$66.20M
EBIT
$66.20M
Pretax Income
-$166.30M
Net Income
-$180.20M
EPS (Diluted)
-3.49
Price & Volume History
Loading chart…
Recent News
Swedish Orphan Biovitrum (BIOVF) Tops Q3 Earnings and Revenue Estimates
Zacks · Oct 27, 2026 6:10 AM ET
Emergent BioSolutions stock falls as CFO plans retirement
Investing.com · Oct 16, 2026 11:41 AM ET
Emergent BioSolutions CFO Richard Lindahl to Retire at Year-End
MT Newswires · Oct 16, 2026 8:34 AM ET
Emergent BioSolutions Announces Retirement of Chief Financial Officer Richard S. Lindahl
Business Wire · Oct 16, 2026 7:50 AM ET
Bioscience Association Manitoba Welcomes New Board Members and Executive Members at Annual General Meeting
Business Wire · Oct 15, 2026 4:10 PM ET
Emergent BioSolutions to Report Third Quarter 2026 Financial Results on November 2, 2026
Business Wire · Oct 15, 2026 8:00 AM ET
Emergent Biosolutions (EBS) Soars 14.4%: Is Further Upside Left in the Stock?
Zacks · Oct 6, 2026 4:07 AM ET
NVAX, EBS, ARCT, MRNA Rally After Russia Plague Lab Worker's Death: Retail Traders Eye 'Contract Awards'
Stocktwits · Oct 5, 2026 11:34 PM ET
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
GlobeNewswire · Sep 15, 2026 7:45 AM ET
Vaccines Global Market Intelligence Report 2026-2035 Featuring Bio Farma, Emergent BioSolutions, GC Pharma, GlaxoSmithKline, Janssen, Merck, Novavax, Moderna, Pfizer, Sanofi Pasteur, and Valneva
GlobeNewswire · Sep 7, 2026 7:02 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See EBS's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.